Louisiana State Employees Retirement System’s Vanda Pharmaceuticals VNDA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-30,100
Closed -$198K 1541
2023
Q2
$198K Buy
30,100
+3,600
+14% +$23.1K ﹤0.01% 1506
2023
Q1
$180K Sell
26,500
-400
-1% -$2.81K ﹤0.01% 1485
2022
Q4
$199K Sell
26,900
-100
-0.4% -$974 0.01% 1478
2022
Q3
$267K Sell
27,000
-300
-1% -$3.17K 0.01% 1410
2022
Q2
$315K Buy
27,300
+200
+0.7% +$2.07K 0.01% 1392
2022
Q1
$305K Buy
27,100
+100
+0.4% +$1.31K 0.01% 1436
2021
Q4
$424K Buy
27,000
+200
+0.7% +$3.48K 0.01% 1368
2021
Q3
$459K Buy
26,800
+1,700
+7% +$29.8K 0.01% 1332
2021
Q2
$540K Buy
25,100
+200
+0.8% +$3.58K 0.01% 1248
2021
Q1
$374K Sell
24,900
-300
-1% -$4.86K 0.01% 1378
2020
Q4
$331K Sell
25,200
-100
-0.4% -$1.2K 0.01% 1348
2020
Q3
$244K Buy
25,300
+10,570
+72% +$113K 0.01% 1310
2020
Q2
$169K Hold
14,730
0.01% 1251
2020
Q1
$153K Sell
14,730
-3,540
-19% -$43.9K 0.01% 1163
2019
Q4
$300K Sell
18,270
-1,430
-7% -$21.6K 0.01% 1238
2019
Q3
$262K Hold
19,700
0.01% 1276
2019
Q2
$269K Hold
19,700
0.01% 1281
2019
Q1
$362K Buy
19,700
+26
+0.1% +$592 0.02% 1186
2018
Q4
$514K Sell
19,674
-3,526
-15% -$82.9K 0.03% 908
2018
Q3
$532K Buy
+23,200
New +$474K 0.02% 1118

Other funds holding VNDA

Louisiana State Employees Retirement System's VNDA Position: Q3 2023 in Review

Louisiana State Employees Retirement System sold out of Vanda Pharmaceuticals (VNDA) in Q3 2023, closing a stake of 30,100 shares — an estimated $198K sold.

Louisiana State Employees Retirement System first reported a position in VNDA in Q3 2018 and held it in 20 quarters. The position peaked at $540K in Q2 2021. 179 funds tracked by Wall St. Rank hold VNDA as of Q3 2023.

  • Louisiana State Employees Retirement System reported no remaining Vanda Pharmaceuticals position as of Q3 2023 after selling out during the quarter.
  • Louisiana State Employees Retirement System sold 30,100 Vanda Pharmaceuticals shares in Q3 2023, an estimated $198K.
  • Louisiana State Employees Retirement System first reported a position in Vanda Pharmaceuticals in Q3 2018 and held it in 20 quarters.
  • Louisiana State Employees Retirement System's Vanda Pharmaceuticals position peaked at $540K in Q2 2021.
  • 179 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q3 2023.

Based on Louisiana State Employees Retirement System's 13F filing for Q3 2023, filed 17 Oct 2023.